|
Status |
Public on Dec 27, 2013 |
Title |
MED1 |
Sample type |
SRA |
|
|
Source name |
CUTLL1
|
Organism |
Homo sapiens |
Characteristics |
cell line: CUTLL1 tumor stage: T lymphoblastic leukemia/lymphoma cell line cell type: T lymphocyte treatment: vehicle antibody: MED1
|
Treatment protocol |
CUTLL1 cells were treated with vehile (DMSO) or GSI (compound E) for 3 days, and treated with GSI for 3 days following by washing and 4 hours of additional treatement in the absence of GSI
|
Growth protocol |
CUTLL1 cells were cultured in RPMI 1640 medium (Invitrogen) supplemented with 10% fetal bovine serum, 2 mM L-glutamine, penicillin and streptomycin
|
Extracted molecule |
genomic DNA |
Extraction protocol |
Lysates were clarified from sonicated nuclei and protein-DNA complexes were isolated with antibody. Libraries were prepared according to New England Biolabs instructions accompanying the DNA Sample Prep Master Mix Set 1 (NEB E6040S).
|
|
|
Library strategy |
ChIP-Seq |
Library source |
genomic |
Library selection |
ChIP |
Instrument model |
Illumina HiSeq 2000 |
|
|
Description |
single read
|
Data processing |
Sequence reads were aligned to the hg19 genome using bowtie Genome_build: hg19 Supplementary_files_format_and_content: peak files
|
|
|
Submission date |
Oct 28, 2013 |
Last update date |
May 15, 2019 |
Contact name |
Chongzhi Zang |
Organization name |
University of Virginia
|
Street address |
P. O. Box 800717
|
City |
Charlottesville |
State/province |
VA |
ZIP/Postal code |
22908 |
Country |
USA |
|
|
Platform ID |
GPL11154 |
Series (1) |
GSE51800 |
NOTCH1/RBPJ complexes drive target gene expression through dynamic interactions with super-enhancers |
|
Relations |
BioSample |
SAMN02385359 |
SRA |
SRX369137 |